scispace - formally typeset
K

Khalid Mashay Al-Anazi

Researcher at King Saud University

Publications -  61
Citations -  893

Khalid Mashay Al-Anazi is an academic researcher from King Saud University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 11, co-authored 50 publications receiving 472 citations. Previous affiliations of Khalid Mashay Al-Anazi include College of Health Sciences, Bahrain.

Papers
More filters
Journal ArticleDOI

Silver nanoparticles synthesized from Adenium obesum leaf extract induced DNA damage, apoptosis and autophagy via generation of reactive oxygen species.

TL;DR: In this article, the authors used aqueous leaf extract of A. obesum (AOAgNPs) for the synthesis of silver nanoparticles, which were further characterized by Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD) and transmission electron microscopy (TEM).
Journal ArticleDOI

Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach.

TL;DR: Bonducellpin D exhibited broad-spectrum inhibition potential against SARS- CoV Mpro and MERS-CoV M Pro and therefore is a promising drug candidate, which needs further validations through in vitro and in vivo studies.
Journal ArticleDOI

An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.

TL;DR: In this paper, the authors highlight two important categories of computer-aided drug design (CADD), viz., the ligand-based as well as structured-based drug discovery.
Journal ArticleDOI

Commiphora molmol protects against methotrexate-induced nephrotoxicity by up-regulating Nrf2/ARE/HO-1 signaling.

TL;DR: In conclusion, C. molmol resin provided protection against MTX-induced AKI via activation of Nrf2 signaling and mitigation of oxidative stress.
Journal ArticleDOI

Comprehensive exploration of the anticancer activities of procaine and its binding with calf thymus DNA: a multi spectroscopic and molecular modelling study

TL;DR: The results showed that the combined treatment with both procaine and doxorubicin enhanced the cytotoxic and apoptotic inducing potential of doxorbicin.